In vitro stability and metabolism of salvinorin A in rat plasma

被引:48
作者
Tsujikawa, K. [1 ]
Kuwayama, K. [1 ]
Miyaguchi, H. [1 ]
Kanamori, T. [1 ]
Iwata, Y. T. [1 ]
Inoue, H. [1 ]
机构
[1] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan
关键词
Salvinorin A; rat plasma; degradation; carboxylesterase; SALVIA-DIVINORUM; LIQUID-CHROMATOGRAPHY; PARAOXONASE; HYDROLYSIS; AGONIST; SERUM; CARBOXYLESTERASE; HALLUCINOGEN; LACTONASE; ESTERASES;
D O I
10.1080/00498250902769967
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Salvinorin A is the main active psychoactive ingredient in Salvia divinorum, a Mexican plant that has been widely available as a hallucinogen in recent years. The aims of this study were to investigate the stability of salvinorin A in rat plasma, esterases responsible for its degradation, and estimation of the degradation products. The apparent first-order rate constants of salvinorin A at 37C, 25C, and 4C were 3.8 10-1, 1.1 10-1, and 6.0 10-3 h-1, respectively. Salvinorin A degradation was markedly inhibited by the addition of sodium fluoride, an esterase inhibitor. Moreover, phenylmethylsulfonyl fluoride (serine esterase inhibitor) and bis-p-nitrophenyl phosphate (carboxylesterase inhibitor) also inhibited salvinorin A degradation. In contrast, little or no suppression of the degradation was seen with 5,5-dithiobis-2-nitrobenzoic acid (arylesterase inhibitor), ethopropazine (butyrylcholinesterase inhibitor), and BW284c51 (acetylcholineseterase inhibitor). These findings indicated that carboxylesterase was mainly involved in the salvinorin A hydrolysis in rat plasma. The degradation products of salvinorin A estimated by liquid chromatography-mass spectrometry included the deacetylated form (salvinorin B) and the lactone-ring-open forms of salvinorin A and salvinorin B. This lactone-ring-opening reactions were involved in calcium-dependent lactonase.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 19 条
[1]   The plant-derived hallucinogen, salvinorin A, produces κ-opioid agonist-like discriminative effects in rhesus monkeys [J].
Butelman, ER ;
Harris, TJ ;
Kreek, MJ .
PSYCHOPHARMACOLOGY, 2004, 172 (02) :220-224
[2]   Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious κ-opioid receptor agonist:: Structural and functional considerations [J].
Chavkin, C ;
Sud, S ;
Jin, WZ ;
Stewart, J ;
Zjawiony, JK ;
Siebert, DJ ;
Toth, BA ;
Hufeisen, SJ ;
Roth, BL .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (03) :1197-1203
[3]   HUMAN LIVER COCAINE ESTERASES - ETHANOL-MEDIATED FORMATION OF ETHYLCOCAINE [J].
DEAN, RA ;
CHRISTIAN, CD ;
SAMPLE, RHB ;
BOSRON, WF .
FASEB JOURNAL, 1991, 5 (12) :2735-2739
[4]   Human carboxylesterase isozymes: Catalytic properties and rational drug design [J].
Imai, Teruko .
DRUG METABOLISM AND PHARMACOKINETICS, 2006, 21 (03) :173-185
[5]   Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma [J].
Li, B ;
Sedlacek, M ;
Manoharan, I ;
Boopathy, R ;
Duysen, EG ;
Masson, P ;
Lockridge, O .
BIOCHEMICAL PHARMACOLOGY, 2005, 70 (11) :1673-1684
[6]   Determination of salvinorins and divinatorins in Salvia divinorum leaves by liquid chromatography/multistage mass spectrometry [J].
Medana, C ;
Massolino, C ;
Pazzi, M ;
Baiocchi, C .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (02) :131-136
[7]   SPECIES-DIFFERENCES IN HYDROLYSIS OF ISOCARBACYCLIN METHYL-ESTER (TEI-9090) BY BLOOD ESTERASES [J].
MINAGAWA, T ;
KOHNO, Y ;
SUWA, T ;
TSUJI, A .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (10) :1361-1365
[8]   Salvinorin A:: A potent naturally occurring nonnitrogenous κ opioid selective agonist [J].
Roth, BL ;
Baner, K ;
Westkaemper, R ;
Siebert, D ;
Rice, KC ;
Steinberg, S ;
Ernsberger, P ;
Rothman, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11934-11939
[9]   DEPENDENCE OF RAT SERUM LACTONASE UPON CALCIUM [J].
ROTH, RH ;
LEVY, R ;
GIARMAN, NJ .
BIOCHEMICAL PHARMACOLOGY, 1967, 16 (03) :596-&
[10]   GAMMA-BUTYROLACTONE AND GAMMA-HYDROXYBUTYRIC ACID .I. DISTRIBUTION AND METABOLISM [J].
ROTH, RH ;
GIARMAN, NJ .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (09) :1333-&